What Galatek does
Galatek builds AI-powered automation for two industries: its Abio software unifies electronic lab notebooks, lab information management and automated lab equipment for life-sciences research, while its semiconductor line covers automated wafer inspection, dicing and overlay metrology. The company says it holds 320 issued patents and works with pharmaceutical firms and institutions including the National University of Singapore. TNGlobal reports Galatek plans to use its Series A to expand supply chain and local teams across Europe, North America and Southeast Asia.
Galatek is an automation tool on Falcoscan. AI automation platform for life-sciences labs and semiconductor fabs. Falcoscan rates Galatek with an Opportunity score of 74/100, a Saturation score of 23/100, and a Wrapper-risk score of 15/100. Market signal: rising. Galatek is founded in 2025, currently at Series_a stage. Pricing: Paid.